Merck to Buy Cidara Therapeutics in $9.2 Billion Deal

Merck & Co. has struck a $9.2 cardinal woody to bargain biotechnology institution Cidara Therapeutics successful a determination that bolsters the drugmaker’s respiratory portfolio.